S100A8 and lung carcinoma: Given that most lung cancers develop on a background of chronic inflammation (26, 27), we hypothesized that the anti-inflammatory properties of S100A8 may limit early-stage growth of lung cancers by favorably modifying the lung immune microenvironment.